Sign In
Labcorp Oklahoma, Inc.
Test Directory


Index:

ThyGenNEXT with Reflex to ThyraMIR

Order Name ThyGenNEXT Rflx
Test Number: 6907017
Revision Date 10/01/2022
Test Name Methodology LOINC Code
ThyGeNEXT
MicroRNA (miRNA) Profiling n/a 
ThyraMIR
MicroRNA (miRNA) Profiling n/a 
Nodule
Specimen Information n/a 
Cytopathology
Patient Information n/a 
Risk Assessment
Calculation n/a 
ThyGen Interpretation
Interpretive information. n/a 
SPECIMEN REQUIREMENTS
Specimen Specimen Volume (min) Specimen Type Specimen Container Transport Environment
Preferred 1 Vial Fine Needle Aspirate RNARetain vial Room Temperature
Instructions ThyGenNext testing is performed following an indeterminate FNA Cytology evaluation.
Contact Labcorp Oklahoma, Inc. for FNA collection kit with special collection vial, instructions and requisition
Specimen collection: Fine needle aspiration of thyroid nodule in RNARetain vial (small amount, 3rd or 4th pass)
Specimen preparation: Send vial with cytology preparations at room temperature
Stability: Ambient - 6 weeks
 
Performing Lab Information and Requisition
GENERAL INFORMATION
Testing Schedule Varies 
Expected TAT 7-14 days after pathology interpretation  
Clinical Use ThyGeNEXT® with Reflex to ThyraMIR® better discriminates benign from malignant nodules and provides risk assessment. TERT and BRAF mutations are included in ThyGeNEXT® . If mutations in ThyGeNEXT® are negative or not fully indicative of malignancy, the ThyraMIR® testing will be performed as reflex. 
Notes INTERFACE ORDERING: ThyGenNEXT Rflx Order should be placed in addition to the electronic Cytology order.
RESULT/REPORT CHANGE: ThyGenNEXT & ThyraMIR were previously reported as an addendum to the FNA Cytology report. They will now be reported from the General Laboratory section.
CPT Code(s) 0245U + 0018U if reflexed
ThyraMIR Molecular testing is reflexed if mutations in ThyGeNEXT are negative or not fully indicative of malignancy.
Lab Section Reference Lab